Subscribe to our newsletter

Inflammatory Bowel Disease Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.
4700 +
STUDY VISITS
2100 +
PATIENTS
100 +
GASTROENTEROLOGISTS

Participating Sites

CorEvitas has clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.
LEARN MORE

Outcome measures in the CorEvitas IBD Registry.

BECOME A SUBSCRIBER

Among the variables we collect, some of the key outcome measures to inform your research include:

Clinician Reported Outcomes

  • Disease location and phenotype
  • IBD-related extraintestinal manifestations

Calculated Measures

  • Harvey-Bradshaw Index (Crohn’s disease)
  • Simple Clinical Colitis Activity Index (SCCAI) (Ulcerative colitis)
  • Mayo Score (partial) (Ulcerative colitis)
  • Simple Endoscopic Score (SES-CD) (Crohn’s disease, if endoscopic score provided)
  • Mayo Severity Index (if flexible proctosigmoidoscopy findings provided)

Patient Reported Outcomes

  • PROMIS – Anxiety, Depression, Fatigue, Sleep Disturbance, Pain Interference
  • Work Productivity and Activity Impairment (WPAI)

Our Publications

MANUSCRIPTS AND ABSTRACTS

Other Registries

Question about a registry?

Contact Us